Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | NOX1 | Q9Y5S8 | 1/20 | 0.36 |
| ▸ | GPR3 | P46089 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | MAOA | P21397 | 1/20 | 0.31 |
| ▸ | MAOB | P27338 | 1/20 | 0.31 |
| ▸ | CA12 | O43570 | 1/20 | 0.30 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | CA9 | Q16790 | 1/20 | 0.30 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.30 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21390569 | 0.84 | KMT2A (0.48) | MEN1KMT2ANOX1GPR3LMNA | |
| SCHEMBL30193036 | 0.84 | KMT2A (0.48) | MEN1KMT2ANOX1GPR3LMNA | |
| SCHEMBL21453622 | 0.76 | ALDH1A1 (0.36) | — | |
| SCHEMBL19319666 | 0.71 | KDM4E (0.37) | MEN1KMT2ANOX1GPR3LMNA | |
| SCHEMBL4734675 | 0.71 | KDM4E (0.37) | MEN1KMT2ANOX1GPR3LMNA | |
| SCHEMBL19319663 | 0.70 | KMT2A (0.36) | MEN1KMT2ANOX1GPR3CA1 | |
| SCHEMBL19325059 | 0.70 | KMT2A (0.36) | MEN1KMT2ANOX1GPR3CA12 | |
| SCHEMBL26502496 | 0.70 | TP53 (0.38) | MEN1KMT2ANOX1GPR3LMNA | |
| SCHEMBL21453950 | 0.69 | GPR3 (0.64) | MEN1KMT2ANOX1GPR3LMNA | |
| SCHEMBL18174538 | 0.69 | MAOA (0.44) | LMNAMAOAMAOBPDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190312210-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-10-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190312210-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SLCO4C1, SLCO2A1, SLCO1A2 | MEN1 1688/4885KMT2A 2917/4885NOX1 1410/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.